NL-OMON52447尚未招募不适用
Relationship between methotrexate polyglutamates in peripheral red and white blood cells with disease activity: towards optimal methotrexate dosing and route of administration in rheumatoid arthritis. - Methotrexate polyglutamates in peripheral blood mononuclear cells
Overige Centra0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosed with rheumatoid arthritis
- •Able to read Dutch texts
- •(only prednisolone (and/or triamcinolonacetonide i.a./i.m.) is allowed as
- •co-medication and no other DMARDs)
排除标准
- •* Rheumatic autoimmune disease other than RA, e.g., systemic lupus
- •erythematosus (SLE), mixed connective tissue disease (MCTD), scleroderma,
- •polymyositis
- •* Subjects who have received an investigational drug within 30 Days prior to
- •the screening visit, known sensitivity to any component of the study drug or
- •previous hypersensitivity reaction or other clinically significant reaction to
- •s.c. medications, any clinically significant hepatic, renal, cardiac,
- •pulmonary, gastrointestinal, metabolic or endocrine disturbances, other medical
- •or psychiatric condition, or clinically relevant abnormal values on any
- •investigation, which in the opinion of the investigator, could make the subject
- •unsuitable for the study, could compromise subject safety, limit the subject*s
- •ability to complete the study, and/or compromise the objectives of the study.
- •History of substance abuse or alcohol abuse.
研究者
相似试验
Unknown
不适用
Relationship between methotrexate in red and white blood cells with disease activity: towards optimal methotrexate dosing in rheumatoid arthritis.NL-OMON20053Reade Reumatology, Amsterdam40
已完成
不适用
Study on the concentration of methotrexate polyglutamates in erythrocytes for the purpose of formulating the evidence-based guideline of diagnosis and treatment on juvenile idiopathic arthritisJuvenile idiopathic arthritisJPRN-UMIN000027373Department of lifetime clinical immunology, Graduate school of medical and dental sciences, Tokyo Medical and Dental University50
已完成
4 期
Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid ArthritisRheumatoid ArthritisNCT00695188Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation19
进行中（未招募）
不适用
Methotrexat-Polyglutamate als Marker fuer das klinische Outcome in der Therapie der rheumatoiden ArthritisRheumatoid ArthritisEUCTR2007-006288-56-ATudwig Boltzmann Cluster für Rheumatologie, Balneologie und Rehabilitation
进行中（未招募）
1 期
Association between metabolits of methotrexate and clinical response in rheumatoid arthritis patientsMedDRA version: 21.0Level: LLTClassification code 10042952Term: Systemic rheumatoid arthritisSystem Organ Class: 100000004859rheumatoid arthritisEUCTR2019-003700-12-FRCHU Saint-Etienne60